Artemis Medicare Services Ltd

Artemis Medicare Services Ltd commenced trading on 1 April 2026 with a notable gap up, opening 6.7% higher than its previous close, signalling a strong start amid positive market sentiment. The stock outperformed its hospital sector peers and broader indices, reflecting a marked shift in trading dynamics after two days of decline.

For the second consecutive session, Artemis Medicare Services Ltd has closed lower, hitting a fresh 52-week low of Rs 205.7 on 30 Mar 2026, marking a 5.05% intraday decline amid broader market weakness.

Artemis Medicare Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 2 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Artemis Medicare Services Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 14 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Artemis Medicare Services Ltd has seen its investment rating downgraded from Hold to Sell, driven primarily by deteriorating technical indicators and sustained underperformance relative to the broader market. Despite solid financial results and healthy long-term growth metrics, the stock faces significant headwinds from bearish technical trends and elevated promoter share pledges, which have intensified selling pressure in recent sessions.

Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a bearish stance. Despite some bullish signals on momentum indicators such as RSI, the overall technical landscape suggests caution for investors as multiple indicators point towards weakening price strength.

Artemis Medicare Services Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a deterioration in the stock’s medium to long-term momentum. Investors should carefully analyse the implications of this event amid the company’s current financial and market performance.

Artemis Medicare Services Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators alongside sustained financial performance. The revised Mojo Score of 54.0 and a Market Cap Grade of 3 underscore a more balanced outlook for the hospital sector company amid mixed market returns and valuation considerations.

Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a modest day gain of 0.80%, the stock’s broader technical outlook remains cautious, with mixed readings from MACD, RSI, moving averages, and other momentum oscillators.

Artemis Medicare Services Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a shift in technical indicators and market sentiment despite solid financial performance. The downgrade, effective 18 Feb 2026, is driven primarily by deteriorating technical trends, valuation concerns, and underwhelming relative returns compared to benchmarks, signalling caution for investors.

Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite some bullish signals on shorter-term indicators, the overall technical landscape suggests caution for investors as the stock grapples with downward pressure amid a recent downgrade in its Mojo Grade to Sell.

Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more sideways trend. Despite a recent upgrade in its Mojo Grade from Sell to Hold, the stock's technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these technical parameters in detail, providing investors with a comprehensive view of the stock’s current market positioning and potential outlook.

Artemis Medicare Services Ltd has recently exhibited a shift in price momentum, transitioning from a sideways trend to a mildly bullish stance. Despite mixed signals from key technical indicators such as MACD, RSI, and moving averages, the stock’s recent performance and upgraded rating suggest cautious optimism for investors in the hospital sector.

Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of early February 2026. Despite a recent upgrade in its Mojo Grade from Sell to Hold, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these developments in detail, placing them in the context of the company’s price performance and broader market trends.

Artemis Medicare Services Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial performance. The upgrade, effective from 09 Feb 2026, is driven by a combination of enhanced technical trends, solid financial metrics, attractive valuation, and a stable quality outlook, signalling a cautious but positive outlook for investors in the hospital sector stock.

Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite mixed signals from key indicators such as MACD and Bollinger Bands, the stock’s recent price action and improving RSI readings suggest cautious optimism for investors navigating the hospital sector.